China Universal Asset Management Co., Ltd. Editas Medicine, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 17,503 shares of EDIT stock, worth $33,605. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,503
Previous 15,863
10.34%
Holding current value
$33,605
Previous $54,000
59.26%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding EDIT
# of Institutions
225Shares Held
54.2MCall Options Held
412KPut Options Held
355K-
Black Rock Inc. New York, NY7.78MShares$14.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$13.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$5.27 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$4.15 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$3.59 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $132M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...